SU1447284A3 - Способ получени производного @ 3Н @ -имидазо- @ 5,1- @ -1,2,3,5-тетразин-4-она - Google Patents

Способ получени производного @ 3Н @ -имидазо- @ 5,1- @ -1,2,3,5-тетразин-4-она Download PDF

Info

Publication number
SU1447284A3
SU1447284A3 SU823482389A SU3482389A SU1447284A3 SU 1447284 A3 SU1447284 A3 SU 1447284A3 SU 823482389 A SU823482389 A SU 823482389A SU 3482389 A SU3482389 A SU 3482389A SU 1447284 A3 SU1447284 A3 SU 1447284A3
Authority
SU
USSR - Soviet Union
Prior art keywords
imidazo
tetrazin
solid
carbamoyl
solution
Prior art date
Application number
SU823482389A
Other languages
English (en)
Russian (ru)
Inventor
Лант Эдвард
Фрэнкис Грахам Стивенс Малкольм
Стоун Роберт
Роберт Харри Вулдридж Кеннет
Original Assignee
Мэй Энд Бейкер Лимитед (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мэй Энд Бейкер Лимитед (Фирма) filed Critical Мэй Энд Бейкер Лимитед (Фирма)
Application granted granted Critical
Publication of SU1447284A3 publication Critical patent/SU1447284A3/ru
Priority to LV930621A priority Critical patent/LV5511A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SU823482389A 1981-08-24 1982-08-23 Способ получени производного @ 3Н @ -имидазо- @ 5,1- @ -1,2,3,5-тетразин-4-она SU1447284A3 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LV930621A LV5511A3 (lv) 1981-08-24 1993-06-19 Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24

Publications (1)

Publication Number Publication Date
SU1447284A3 true SU1447284A3 (ru) 1988-12-23

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
SU823482389A SU1447284A3 (ru) 1981-08-24 1982-08-23 Способ получени производного @ 3Н @ -имидазо- @ 5,1- @ -1,2,3,5-тетразин-4-она

Country Status (29)

Country Link
JP (1) JPS5843975A (enExample)
KR (1) KR890000094B1 (enExample)
AT (1) AT380256B (enExample)
AU (1) AU571430B2 (enExample)
BE (1) BE894175A (enExample)
CA (1) CA1197247A (enExample)
CH (1) CH655114A5 (enExample)
DE (2) DE3231255A1 (enExample)
DK (1) DK161147C (enExample)
ES (1) ES8400438A1 (enExample)
FI (1) FI73434C (enExample)
FR (1) FR2511679A1 (enExample)
GB (1) GB2104522B (enExample)
GE (1) GEP19960641B (enExample)
GR (1) GR76863B (enExample)
HU (1) HU186107B (enExample)
IE (1) IE53408B1 (enExample)
IL (1) IL66606A (enExample)
IT (1) IT1152505B (enExample)
LT (1) LT2436B (enExample)
LU (1) LU84347A1 (enExample)
LV (2) LV5511A3 (enExample)
NL (2) NL192739C (enExample)
NZ (1) NZ201668A (enExample)
OA (1) OA07174A (enExample)
SE (1) SE448543B (enExample)
SU (1) SU1447284A3 (enExample)
UA (1) UA5971A1 (enExample)
ZA (1) ZA826120B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
RU2166946C2 (ru) * 1995-09-25 2001-05-20 Санофи-Синтелабо Инк. Состав, содержащий 1,2,4-бензотриазин-3-амин-1,4-диоксид, для парентерального введения и способ лечения с его применением
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
GR78688B (enExample) * 1982-08-17 1984-09-27 May & Baker Ltd
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
BRPI0417117A (pt) * 2003-12-30 2007-03-06 Chemagis Ltd temozolomida cristalizada, processo de preparação de temozolomida cristalizada, composição farmacêutica, método de produção de medicamento contendo temozolomida e método de tratamento de uma condição médica para a qual a termozolomida é benéfica
CA2594477C (en) 2005-01-21 2016-07-12 Astex Therapeutics Limited Pharmaceutical compounds
PE20080695A1 (es) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8329711B2 (en) 2007-10-23 2012-12-11 Msd K.K. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
US8716471B2 (en) * 2008-11-24 2014-05-06 Reliance Life Sciences Pvt. Ltd. Process for the preparation of tetrazine derivatives
EP2403339B1 (en) 2009-03-06 2017-01-18 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
CA2763766A1 (en) 2009-06-23 2010-12-29 Pharminox Limited 3-substituted-8-substituted-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
ES3057783T3 (en) 2016-03-15 2026-03-04 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Tveit К,М., Fodstad О., Olsnes S., Rinl А. In vitro sensitivity of Inmati inelanoma xenografts to cytotoxic drugs. Correlation with in vivo che- mosepsitivity. Inst. I.Cancer. 26, i980i p.. 717-722. Патент СССР f 1227117, pi. С 07 H 15/24, 22.08,81. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
RU2166946C2 (ru) * 1995-09-25 2001-05-20 Санофи-Синтелабо Инк. Состав, содержащий 1,2,4-бензотриазин-3-амин-1,4-диоксид, для парентерального введения и способ лечения с его применением
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ

Also Published As

Publication number Publication date
KR840001175A (ko) 1984-03-28
SE448543B (sv) 1987-03-02
BE894175A (fr) 1983-02-23
ES515176A0 (es) 1983-11-01
FI822921A0 (fi) 1982-08-23
DE3231255A1 (de) 1983-03-03
FR2511679B1 (enExample) 1985-02-01
GB2104522B (en) 1985-06-12
AU8749382A (en) 1983-03-03
NZ201668A (en) 1985-08-16
FI73434B (fi) 1987-06-30
FI73434C (fi) 1987-10-09
ATA319182A (de) 1985-09-15
LV5621A3 (lv) 1994-05-10
UA5971A1 (uk) 1994-12-29
LU84347A1 (fr) 1983-06-07
NL8203286A (nl) 1983-03-16
KR890000094B1 (ko) 1989-03-07
IT8222938A1 (it) 1984-02-23
AT380256B (de) 1986-05-12
IE53408B1 (en) 1988-11-09
CA1197247A (fr) 1985-11-26
GB2104522A (en) 1983-03-09
JPS5843975A (ja) 1983-03-14
DK161147C (da) 1991-11-18
IL66606A0 (en) 1982-12-31
ES8400438A1 (es) 1983-11-01
NL192739C (nl) 1998-01-06
CH655114A5 (fr) 1986-03-27
NL990010I1 (nl) 1999-07-01
SE8204817L (sv) 1983-02-25
AU571430B2 (en) 1988-04-21
DE3231255C2 (enExample) 1992-02-27
IL66606A (en) 1987-07-31
DE19975037I2 (de) 2001-06-13
FR2511679A1 (fr) 1983-02-25
NL990010I2 (nl) 1999-09-01
NL192739B (nl) 1997-09-01
GR76863B (enExample) 1984-09-04
DK161147B (da) 1991-06-03
HU186107B (en) 1985-06-28
ZA826120B (en) 1983-07-27
JPH045029B2 (enExample) 1992-01-30
OA07174A (fr) 1984-04-30
IE822026L (en) 1983-02-24
FI822921L (fi) 1983-02-25
IT1152505B (it) 1987-01-07
DK377882A (da) 1983-02-25
SE8204817D0 (sv) 1982-08-23
LT2436B (lt) 1994-02-15
LV5511A3 (lv) 1994-03-10
IT8222938A0 (it) 1982-08-23
GEP19960641B (en) 1996-11-15

Similar Documents

Publication Publication Date Title
EP0041355B1 (en) Novel erythromycin compounds
EP0299470B1 (de) Imidazo[1,2-a]pyridine
EP0486565B1 (en) Discodermolide compounds, compositions containing same and methods of preparation and use
KR890000094B1 (ko) [3H]-이미다조[5, 1-d]-1, 2, 3, 5-테트라진-4-온 유도체의 제조방법
DE3853711T2 (de) Zwischenverbindungen für die Synthese von 5,6,7,8-Tetrahydro-L-erythro-biopterin und seiner Derivate.
AT394853B (de) Verfahren zur herstellung von neuen mitosanderivaten
AT394725B (de) Verfahren zur herstellung von neuen mitomycin-c-analogen
US4007169A (en) Method of preparing derivatives of rifamycin S
JPH01193282A (ja) Ｌｌ−ｅ３３２８８の二イオウ類似体
US5637703A (en) Derivatives of genistein
CN110272450A (zh) 一种β-硫羰基双膦酰类衍生物及其制备方法
JPH0569111B2 (enExample)
RU2132841C1 (ru) Способ очистки окситетрациклина и промежуточный продукт
EP0410727A1 (en) Processes for removing allyl groups
DE69111640T2 (de) 7-(Diphenylmethyl)oxy-9a-methoxymitosan, seine Herstellung und Verwendung.
AT394724B (de) Verfahren zur herstellung von n7-amidino-substituierten mitomycin-c-derivaten
RU2790399C1 (ru) Способ получения 4-галоген-1Н-пирроло[3,4-с]пиридин-1,3(2Н)-дионов
EP0128370A2 (en) Diazotetracyclic compounds and process for preparing the same
EP0167045A1 (de) Benzo (c)(1,8)naphthyridine, Verfahren zu ihrer Herstellung und ihre Verwendung sowie diese Verbindungen enthaltende Zubereitungen
CH527846A (de) Verfahren zur Herstellung von Penicillinderivaten
DE2741066A1 (de) Neue rifamyzin-verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE2746209A1 (de) Neues antibiotikum und verfahren zu dessen herstellung
SU550829A1 (ru) Производные дипиримидо [(4,5 - @ )(5,4 - @ )]-(1,4)тиазинов и способ их получени
SU1544774A1 (ru) Способ получени мононитробензокраун-эфиров
AT397092B (de) Verfahren zur herstellung von neuen mitosan-derivaten